| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$12 |
Bloodwood Gold Project Granted
|
1 Sep 2026 10:23AM |
$0.045 |
$0.052 |
risen by
15.56%
|
|
DUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration Licence E38/4002 was granted on 18 August 2026 and announced on 1 September 2026.
- The licence covers about 270km² across 89 blocks in the Mount Margaret Mineral Field at the Romano Project.
- The grant secures the entire 5km Bloodwood gold anomaly, Dundas’ most advanced target at Romano.
- Historical air core drilling returned 12m at 3.31 g/t gold from 20m including 4m at 9.53 g/t gold.
- Historical diamond drilling beneath the air core result returned 2.95m at 1.95 g/t gold from 113.45m including 1.7m at 3.29 g/t gold.
- Bloodwood lies on the Yamarna Shear Zone corridor, about 20km north of the Golden Highway deposits and 35km northwest of the Gruyere gold mine.
- Dundas emphasised that drilling to date has been shallow, widely spaced and first pass, with limited testing along strike and at depth.
- No ground disturbing work can begin until native title access, heritage clearance and reserve entry approvals are obtained.
- The licence is registered to Cazaly Resources and Dundas is earning an 80% interest in the Romano Project.
- The licence grant triggers a milestone payment of $150,000 cash and $150,000 in Dundas shares subject to shareholder approval, otherwise cash is payable instead.
- The minimum annual expenditure commitment on E38/4002 is $89,000 and the licence term is five years from grant.
- Dundas plans to progress access approvals, reinterpret historical datasets and design a first systematic reverse circulation and diamond drilling program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$446 |
Initial Director's Interest Notice - Karim Temsamani
|
1 Sep 2026 10:21AM |
$5.390 |
$5.385 |
fallen by
0.09%
|
|
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$10,146 |
Change of Director's Interest Notice
|
1 Sep 2026 10:21AM |
$21.800 |
$19.990 |
fallen by
8.30%
|
|
| Scentre Group (SCG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$18,198 |
Initial Director's Interest Notice - Karim Temsamani
|
1 Sep 2026 10:20AM |
$3.545 |
$3.480 |
fallen by
1.83%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$542 |
Purchase of Shares to Satisfy Dividend Reinvestment Plan
|
1 Sep 2026 10:20AM |
$2.590 |
$2.340 |
fallen by
9.65%
|
|
| BMC Minerals Ltd. (BMC) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$687 |
Corporate Presentation
|
1 Sep 2026 10:20AM |
$3.080 |
$2.500 |
fallen by
18.83%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$4 |
Caisson Project Nevada- landholding expanded, work commences
|
1 Sep 2026 10:19AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$2,615 |
Cleansing Notice
|
1 Sep 2026 10:16AM |
$9.670 |
$9.320 |
fallen by
3.62%
|
|
| QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$38,758 |
Initial Director's Interest Notice
|
1 Sep 2026 10:16AM |
$22.350 |
$25.940 |
risen by
16.06%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$261,847 |
Ceasing to be a substantial holder for KAR
|
1 Sep 2026 10:15AM |
$160.170 |
$156.470 |
fallen by
2.31%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,201 |
Ceasing to be a substantial holder from CBA
|
1 Sep 2026 10:15AM |
$1.763 |
$1.723 |
fallen by
2.27%
|
|
| Love Group Global Ltd (LVE) ORDINARY FULLY PAID |
Communication Services |
$4 |
Return of Capital - LVE
|
1 Sep 2026 10:15AM |
$0.095 |
$0.100 |
risen by
5.26%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$174 |
Proposed issue of securities - ACW
|
1 Sep 2026 10:14AM |
$0.044 |
$0.045 |
risen by
2.27%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$174 |
ACW unlisted options fully underwritten
|
1 Sep 2026 10:12AM |
$0.044 |
$0.045 |
risen by
2.27%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen Medical entered into an underwriting agreement with Forrest Capital Pty Ltd for the remaining unlisted ACWAP and ACWAO options.
- The underwriting covers 127,235,644 outstanding unexercised options with an exercise price of 3.75 cents each.
- If fully exercised, the underwritten options will provide approximately $4,771,336.65 in additional funding to Actinogen.
- The options were originally issued as part of the company’s September 2023 non-renounceable rights issue.
- Approximately 72,793,549 options from the two tranches had already been exercised, raising about $2,729,758.
- The remaining outstanding options comprised 65,573,727 ACWAP options and 61,661,917 ACWAO options.
- Actinogen expects to issue the ordinary shares relating to any shortfall to Forrest or its nominees on 23 September 2026.
- Forrest will receive an underwriting fee of 5.0% of the underwritten amount plus GST, along with reasonable costs and expenses.
- Any shortfall shares issued under the underwriting agreement will fall under ASX Listing Rule 7.2 Exception 10 and will not affect the company’s placement capacity or require shareholder approval.
- Actinogen said the underwriting secures its cash runway to late CY2027 or early CY2028 when combined with its $16.7 million June-end cash balance and expected R&D tax incentive rebate.
- The company highlighted that the pivotal XanaMIA Alzheimer’s disease trial remains on track for topline final results in November 2026.
- Actinogen also noted strong enrolment in the XanaMIA open-label extension, publication of positive depression trial findings, progress on new patents, and regulatory alignment with the EMA and US FDA.
- The appendix outlined standard termination events for the underwriting agreement, including market falls, regulatory action, inability to issue shares, breaches, adverse changes, insolvency, litigation and capital structure changes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Megaport Limited (MP1) ORDINARY FULLY PAID |
Information Technology |
$3,796 |
Notification regarding unquoted securities - MP1
|
1 Sep 2026 10:11AM |
$16.250 |
$15.950 |
fallen by
1.85%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$53 |
Notification of cessation of securities - M7T
|
1 Sep 2026 10:10AM |
$0.280 |
$0.225 |
fallen by
19.64%
|
|
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$14 |
FY26 Half Yearly Results Presentation
|
1 Sep 2026 10:10AM |
$0.115 |
$0.130 |
risen by
13.04%
|
|
MFD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue was $41.3 million, down 6.0% versus HY25.
- Average HY26 occupancy was 51.3%, down from 52.6% in HY25, while spot occupancy improved to 54.4% in the week commencing 24 August 2026.
- Underlying centre EBITDA was $3.1 million with a 7.5% margin, broadly stable despite lower occupancy.
- Underlying group EBITDA was a loss of $0.8 million compared with a loss of $0.1 million in HY25.
- Wage-to-revenue improved 1.9 percentage points to 61.5% as labour costs fell despite annual award wage increases.
- Statutory NPAT was a loss of $31.9 million after $29.0 million of non-cash impairment charges, including $10.9 million goodwill impairment and $18.1 million right-of-use asset impairment.
- Operating cash inflow was $0.9 million and capital expenditure was $0.9 million.
- Cash at 30 June 2026 was $0.2 million, borrowings were $5.5 million and net assets were $16.5 million.
- Post period end, Mayfield completed a $3.0 million entitlement offer, raising about $2.8 million net, and extended its Westpac facility to 3 September 2027.
- Available liquidity was about $3.6 million at 30 June 2026 and about $5.2 million at 31 August 2026 on a pro forma basis.
- Family advocacy remained strong with a net promoter score of +69, up from +65 in HY25.
- 96% of centres were rated Meeting or Exceeding the National Quality Standard, above the 91% sector benchmark.
- The centre-led enrolment model showed improving momentum, with 139 pre-enrolments, an 82% conversion rate and 114 expected commencements.
- Mayfield announced structural cost reduction and portfolio actions expected to deliver about $2.6 million in annualised earnings improvement once fully implemented.
- The portfolio comprised 45 centres at 30 June 2026, with three centres identified for portfolio action, resulting in a pro forma continuing portfolio of 42 centres.
- FY26 earnings guidance had been withdrawn on 10 July 2026, with revised guidance expected during September 2026.
- The appendix outlined Mayfield 360, an allied health initiative operating in 8 centres, with management targeting about $1.0 million of annual EBITDA at scale from the initial clinical service stream.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$123,187 |
Initial Director's Interest Notice
|
1 Sep 2026 10:07AM |
$38.420 |
$39.515 |
risen by
2.85%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$4 |
Cleansing Notice
|
1 Sep 2026 10:06AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,791 |
Notification of cessation of securities - ORA
|
1 Sep 2026 10:04AM |
$1.450 |
$1.465 |
risen by
1.03%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$12,442 |
Final Director's Interest Notice - C Suessmuth Dyckerhoff
|
1 Sep 2026 10:04AM |
$52.140 |
$53.900 |
risen by
3.38%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$4 |
Application for quotation of securities - IBX
|
1 Sep 2026 10:04AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$483 |
Court of Appeal Judgement Update
|
1 Sep 2026 10:02AM |
$5.120 |
$3.970 |
fallen by
22.46%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$11 |
Maiden RC Drilling Underway at Khaleesi
|
1 Sep 2026 9:59AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Carma Limited (CMA) ORDINARY FULLY PAID |
Consumer Discretionary |
$83 |
Retail Deliveries Update August
|
1 Sep 2026 9:59AM |
$0.810 |
$0.605 |
fallen by
25.31%
|
|